Here, we evaluate the functional role of CYP2E1 in obesity and the therapeutic potential of a highly selective CYP2E1 inhibitor, 4-methyl-5-acetylthiazole (Q11). Here, CYP2E1 is linked to obesity due to melanocortin 4 receptor deficiency.